Preliminary evaluation of anticonvulsant activity of some aroxyacetamides and aroxyethylamines

Acta Poloniae Pharmaceutica - Drug Research

Volumn 62, Issue 5, 2005, Pages 345-353

  Marona, Henryk ^a   Waszkielewicz, Anna M ^a   Szneler, Edward ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Anticonvulsant activity; Aroxyacetamides; Aroxyethylamines

Indexed keywords

ACETAMIDE DERIVATIVE; ANTICONVULSIVE AGENT; CONVULSANT AGENT; ETHYLAMINE; PENTETRAZOLE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; ELECTRIC SHOCK; MOUSE; SEIZURE; SYNTHESIS;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; CONVULSANTS; ELECTROSHOCK; ETHYLAMINES; MICE; PENTYLENETETRAZOLE; SEIZURES;

EID: 33644978571     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lindhout D., Omtzigt J.G.C.: Epilepsia 35, 19 (1990).
2. Stables J.P., Kupferberg H.J.: The NIH anticon-vulsant drug development (ADD) program: pre-clinical anticonvulsant screening project. John Libey&Co., 1997.
3. Rajtar G., Zótkowska D., Kleinrok Z., Marona H.: Acta Pol. Pharm.- Drug Res. 56,311 (1999).
4. Schachter S.C.: Medscape Neurology 2 (2000).
5. Mueller T.H., Beeber A.R.: Am. J. Psych. 161, 1128(2004).
6. Sankar R., Holmes G.L.: J. Child Neurol. 19, 6 (2004).
7. Vida J.A.: in: Principles of medicinal chemistry. Foye W.O., Lemke T.L., Williams D.A. Eds. p. 182., Williams and Wilkins, 4th ed., Philadelphia, 1995.
8. Musso D.L., Boswell G.E., Mehta N.B., Soroko F.E., Burchall C.J.: Eur. J. Med. Chem. 31, 331 (1996).
9. Chufan E.E., Pedregosa J.C., Baldini O.N., Bruno-Blanch L.:' II Farmaco 54, 838 (1999).
10. Soyer Z., Kilic S.F., Erol K., Pabuccuoglu V.: 11 Farmaco 59, 595 (2003).
11. Marona H., Antkiewicz-Michaluk L.: Acta Pol. Pharm.-Drug Res. 55,487 (1998).
12. Usifoch CO., Lambert D.M., Wouters J., Scriba G.K.E.: Arch. Pharm. Pharm. Med. Chem. 334, 323 (2001).
13. Andurkar S.V., Beguin C, Stables J.P., Kohn K.: J. Med. Chem. 44, 1475 (2001).
14. Madsen U., Brauner-Osbome H., Frydenvang K., Hvene L., Johansen T.N., Nielsen B., Sanchez C, Stensbol T.B., Bischoff F., Krogsgaard-Larsen P.: J. Med. Chem. 44, 1051 (2001).
15. Paruszewski R., StrusiŃska M., Stables J.P., Śvviader M., Czuczwar S., Kleinrok Z., Turski W.: Chem. Pharm. Bull. 49, 629 (2001).
16. Vamecq J., Lambert D., Poupaert J.: J. Med. Chem. 41, 3307 (1998).
17. Klitgaard H., Matagne A., Gobert J.: Eur. J. Pharmacol. 353, 191 (1998).
18. Wamil A., Cheung H., Harris E.:Έpilepsy Res. 23, 1 (1996).
19. Marona. H., Szneler E.: Acta Pol. Pharm. - Drug Res. 60, 477 (2003).
20. Mulzac D., Scott K.R.: Epilepsia 34, 1141 (1993).
21. Marona H., Pçkala E.: Acta Pol. Pharm.-Drug Res. 53, 111 (1996).
22. Marona H., Korona R., Szneler E.: Boll. Chim. Farmac. - Anno 143, 329 (2004).